Subcutaneous granuloma pyogenicum in patients with antiphospholipid antibodies

Dermatology

Volumn 208, Issue 4, 2004, Pages 331-334

  Kuroda, Kei ^a   Mizoguchi, Masako ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Shimotsuga General Hospital   (Japan)

Author keywords

Antiphospholipid antibody; Subcutaneous granuloma pyogenicum

Indexed keywords

CARDIOLIPIN ANTIBODY; HEPARIN; PHOSPHOLIPID ANTIBODY; STEROID; WARFARIN;

ADULT; AGED; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; LABORATORY TEST; LIVEDO RETICULARIS; LUNG INFARCTION; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PYOGENIC GRANULOMA; SUBCUTANEOUS NODULE; THROMBOCYTOPENIA; THROMBOPHLEBITIS;

AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; EXTREMITIES; FEMALE; GRANULOMA, PYOGENIC; HUMANS; MALE; MIDDLE AGED; SKIN DISEASES;

EID: 2942583359     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077842     Document Type: Article

References (16)

1. Cooper PH, Mills SE: Subcutaneous granuloma pyogenicum: Lobular capillary hemangioma. Arch Dermatol 1982;118:30-33.
2. Wilson WA, Gharavi AE, Koike T, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999;42:1309-1311.
3. Naldi L, Locati F, Marchesi L, Cortelazzo S, Finazzi G, Galli M, Brevi A, Cainelli T, Barbui T: Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: A case-control study. Ann Rheum Dis 1993;52:219-222.
4. Mackworth-Young CG, Loizou S, Walport MJ: Primary antiphospholipid syndrome: Features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989;48:362-367.
5. Manganelli P, Lisi R, Saginario A, Benoldi D: Sneddon's syndrome and primary antiphospholipid syndrome: A case report. J Am Acad Dermatol 1992;26:309-311.
6. Naldi L, Finazzi G, Brevi A, et al. Antiphospholipid antibodies and melanoma: A link? Dermatology 1992;184:156.
7. Stephansson EA, Niemi KM: Antiphospholipid antibodies and anetoderma: Are they associated? Dermatology 1995;191:204-209.
8. Alvarez-Cuesta CC, Raya-Aguado C, Fernandez-Rippe ML, Sanchez TS, Perez-Oliva N: Anetoderma in a systemic lupus erythematosus patient with anti-PCNA and antiphospholipid antibodies. Dermatology 2001;203:348-350.
9. Carmeliet P: Biomedicine: Clotting factors build blood vessels. Science 2001;293:1602-1604.
10. Rongioletti F, Rebora A: Cutaneous reactive angiomatoses: Patterns and classification of reactive vascular proliferation. J Am Acad Dermatol 2003;49:887-896.
11. McMenamin ME, Fletcher CD: Reactive angioendotheliomatosis: A study of 15 cases demonstrating a wide clinicopathologic spectrum. Am J Surg Pathol 2002;26:685-697.
12. Kim YC, Park HJ, Cinn YW: Microvenular hemangioma. Dermatology 2003;206:161-164.
13. LeBoit PE, Solomon AR, Santa Cruz DJ, Wick MR: Angiomatosis with luminal cryoprotein deposition. J Am Acad Dermatol 1992;27:969-973.
14. Creamer D, Black MM, Calonje E: Reactive angioendotheliomatosis in association with the antiphospholipid syndrome. J Am Acad Dermatol 2000;42:903-906.
15. Thai KE, Barrett W, Kossard S: Reactive angioendotheliomatosis in the setting of antiphospholipid syndrome. Australas J Dermatol 2003;44:151-155.
16. Reyes E, Alarcon-Segovia D: Leg ulcers in the primary antiphospholipid syndrome: Report of a case with a peculiar proliferative small vessel vasculopathy. Clin Exp Rheumatol 1991;9:63-66.